Skip to main content
. 2019 Jan-Feb;35(1):61–65. doi: 10.12669/pjms.35.1.91

Table-I.

Baseline characteristics, frequency and causes of anemia in lymphoma patients (N-408).

Variables Frequency - N (%) Variables Frequency - N (%)
Age in years Extra Nodal involvement
18-30 197 (48.3%) Absent 283 (69.4%)
31-40 131 (32.1%) Present 125 (30.6%)
Above 40 80 (19.6%) Bone marrow involvement
Sex Absent 306 (75.0%)
Male 272 (66.7%) Present 83 (20.3%)
Female 136 (33.3%) Not Done 19 (4.7%)
Diagnosis Bulky disease
Hodgkin Lymphoma 201 (49.3%) Absent 247 (60.5%)
Non Hodgkin Lymphomas
DLBCL* 134 (32.8%) Present 161 (39.5%)
Follicular Lymphoma 18 (4.4%) Anemia
Burkitts lymphoma 16 (3.9%)
Marginal zone lymphoma 11 (2.7%) Absent 224 (54.9%)
Natural Killer cells 4 (1.0%) Present 184 (45.1%)
Others# 24 (5.9%) Grades of Anemia
Stage No Anemia 224 (54.9%)
I 59 (14.5%) Mild Anemia 37 (9.1%)
II 76 (18.6%) Moderate Anemia 124 (30.4%)
III 77 (18.9%) Severe Anemia 23 (5.6%)
IV 196 (48.0%) Causes of Anemia
B-Symptoms Anemia of chronic disease 61 (33.1%)
Absent 128 (31.4%) Marrow involvement anemia 50 (27.17%)
Present 280 (68.6%) Iron deficiency anemia 14 (7.6%)
Splenomegaly B-12 deficiency anemia 3 (1.6%)
Hemolytic anemia 1 (0.54%)
Absent 290 (71.1%) Incomplete work up 55 (29.89%)
Present 118 (28.9%)
*

Diffuse large B-cell lymphoma,

#

Lymphomatoid granulomatosis, Mantle cell lymphoma, Gastric MALT, anaplastic large cell lymphoma, T cell rich large B cell lymphoma.